- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 56.65M sh |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $666.91M |
| Long Term Debt | Q1 2025 · Mar 31, 2024 | $673.54M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $10.48M |
| Short Term Debt | Q1 2025 · Mar 31, 2024 | $7.07M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $236.8M |
| Cash And Equivalents restated | Q1 2025 · Mar 31, 2024 | $128.36M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $370.04M |
| Current Liabilities | Q1 2025 · Mar 31, 2024 | $297.23M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.38B |
| Total Liabilities | Q1 2025 · Mar 31, 2024 | $1.3B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $987.67M |
| Current Assets | Q1 2025 · Mar 31, 2024 | $817.76M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.85B |
| Total Assets | Q1 2025 · Mar 31, 2024 | $2.51B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 56.59M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $43.69M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$43.21M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.22B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.27B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.84 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.84 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $60.22M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$47.63M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$53.73M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $6.49M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $323.1M |